12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Friday's intraday session, several healthcare stocks experienced significant movements. PaxMedica (PXMD) led the gainers with a 110.9% increase, while Motus GI Holdings (MOTS) saw the largest decline at 39%. Other notable movers include Q32 Bio (QTTB), Cyclacel Pharmaceuticals (CYCCP), and Rani Therapeutics Holdings (RANI) among the gainers, and Monogram Orthopaedics (MGRM) and BioSig Technologies (BSGM) among the losers.
April 12, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cyclacel Pharmaceuticals (CYCCP) shares increased by 20.45% to $21.2.
The increase in CYCCP's stock price could indicate a positive market response to company developments, potentially leading to more short-term increases.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
PaxMedica (PXMD) stock soared by 110.9% to $0.87, with a market cap of $6.4 million.
The significant increase in PXMD's stock price could attract more investor attention to the stock, potentially leading to short-term price volatility.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Q32 Bio (QTTB) shares rose 23.89% to $29.5, with a market value of $351.9 million.
QTTB's significant price increase reflects positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Rani Therapeutics Holdings (RANI) shares moved upwards by 17.48% to $5.25, with a market value of $136.7 million.
RANI's stock price increase could be driven by positive investor sentiment or company news, suggesting potential for further short-term gains.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Motus GI Holdings (MOTS) shares declined by 39% to $0.26, with a market cap of $1.3 million.
The sharp decline in MOTS's stock price could lead to negative sentiment among investors, potentially causing further short-term declines.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100